title: Severe manic episode associated with tramadol in a patient with recurrent depressive disorder.
authors: Unit of Pharmacogenetics and Clinical Psychopharmacology Department of Psychiatry Center for Psychiatric Neurosciences Lausanne University Hospital Hospital of Cery Prilly, Lausanne, Switzerland Department of Psychiatry Lausanne University Hospital Hospital of Cery Prilly, Lausanne, Switzerland Unit of Pharmacogenetics and Clinical Psychopharmacology Department of Psychiatry Center for Psychiatric Neurosciences Lausanne University Hospital Hospital of Cery Prilly, Lausanne, Switzerland School of Pharmaceutical Sciences University of Geneva University of Lausanne Geneva, Switzerland chin.eap@chuv.ch.
authors: Nicolas
authors: N
authors: Ansermot
authors: Oury
authors: O
authors: Chocron
authors: Fabrice
authors: F
authors: Herrera
authors: Chin B
authors: CB
authors: Eap
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000523:psychology; D015283:Citalopram / Q000627:therapeutic use; D003866:Depressive Disorder / Q000150:complications* / Q000523:psychology; D004347:Drug Interactions; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use; D017116:Low Back Pain / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D000069348:Quetiapine Fumarate / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use; D014147:Tramadol / Q000009:adverse effects*
chemical_list: D000701:Analgesics, Opioid; D018687:Antidepressive Agents, Second-Generation; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D013431:Sulfates; D015283:Citalopram; D000069348:Quetiapine Fumarate; D014147:Tramadol; C054097:lithium sulfate